The News
Absci Corporation has granted a non-statutory stock option for 650,000 shares to a key executive. This move aligns with Nasdaq listing requirements and reflects the company's ongoing commitment to incentivize leadership.
Why It Matters
The stock options were granted on March 3, 2026, as part of a strategy to attract and retain talent in the competitive biopharmaceutical sector. This is a common practice for companies aiming to align executive interests with shareholder value.
Key Evidence
The announcement was made via a press release on Globe Newswire, highlighting the specifics of the stock option grant and its compliance with Nasdaq regulations.
Source
aktiencheck
DE source 路 Published 2d ago